APGE
Price
$47.67
Change
+$0.65 (+1.38%)
Updated
Dec 20, 04:59 PM (EDT)
79 days until earnings call
IMNM
Price
$10.99
Change
-$0.09 (-0.81%)
Updated
Dec 20, 04:59 PM (EDT)
94 days until earnings call
Ad is loading...

APGE vs IMNM

Header iconAPGE vs IMNM Comparison
Open Charts APGE vs IMNMBanner chart's image
Apogee Therapeutics
Price$47.67
Change+$0.65 (+1.38%)
Volume$27.15K
CapitalizationN/A
Immunome
Price$10.99
Change-$0.09 (-0.81%)
Volume$30.71K
CapitalizationN/A
APGE vs IMNM Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. IMNM commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and IMNM is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (APGE: $47.71 vs. IMNM: $10.97)
Brand notoriety: APGE and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 126% vs. IMNM: 182%
Market capitalization -- APGE: $2.71B vs. IMNM: $685.96M
APGE [@Biotechnology] is valued at $2.71B. IMNM’s [@Biotechnology] market capitalization is $685.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, both APGE and IMNM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 4 TA indicator(s) are bullish while IMNM’s TA Score has 4 bullish TA indicator(s).

  • APGE’s TA Score: 4 bullish, 6 bearish.
  • IMNM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both APGE and IMNM are a bad buy in the short-term.

Price Growth

APGE (@Biotechnology) experienced а +7.21% price change this week, while IMNM (@Biotechnology) price change was -12.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

APGE is expected to report earnings on Mar 11, 2025.

IMNM is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.72B) has a higher market cap than IMNM($686M). APGE YTD gains are higher at: 70.759 vs. IMNM (2.523). IMNM has higher annual earnings (EBITDA): -109.95M vs. APGE (-169.13M). APGE has more cash in the bank: 526M vs. IMNM (240M). IMNM has less debt than APGE: IMNM (2.72M) vs APGE (12.1M). IMNM has higher revenues than APGE: IMNM (10.1M) vs APGE (0).
APGEIMNMAPGE / IMNM
Capitalization2.72B686M396%
EBITDA-169.13M-109.95M154%
Gain YTD70.7592.5232,804%
P/E RatioN/AN/A-
Revenue010.1M-
Total Cash526M240M219%
Total Debt12.1M2.72M445%
TECHNICAL ANALYSIS
Technical Analysis
APGEIMNM
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bullish Trend 3 days ago
70%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 14 days ago
81%
Declines
ODDS (%)
Bearish Trend 13 days ago
74%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BBGSX16.510.20
+1.23%
Bridge Builder Small/Mid Cap Growth
BGEIX12.270.12
+0.99%
American Century Global Gold Inv
DIEFX12.560.03
+0.24%
Destinations International Equity I
MPITX13.420.01
+0.07%
BNY Mellon International M
RLSMX12.03-1.25
-9.41%
Lazard US Small Cap Equity Select R6

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+1.47%
SYRE - APGE
44%
Loosely correlated
+3.16%
BHVN - APGE
43%
Loosely correlated
+2.60%
ACLX - APGE
38%
Loosely correlated
+0.44%
ALLO - APGE
38%
Loosely correlated
+1.63%
IMNM - APGE
35%
Loosely correlated
-0.99%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-0.99%
BEAM - IMNM
46%
Loosely correlated
+8.04%
INZY - IMNM
46%
Loosely correlated
+6.41%
ATXS - IMNM
44%
Loosely correlated
+1.16%
RXRX - IMNM
43%
Loosely correlated
-0.99%
JSPR - IMNM
43%
Loosely correlated
+0.19%
More